Elypta's Urine Biomarker Study: Breakthrough in Cancer Risk
What's Going on with Elypta? Well, isn't this an intriguing twist in cancer risk prediction? A Swedish company, Elypta, just tossed its hat into the medicinal ring with some fascinating findings. They're leveraging a study that analyzes urine biomarkers to predict cancer risk over a five-year span. Tackling a whopping cohort of 5,436 adults, it's as ambitious as it...
Continue Reading